Abstract

BackgroundA recent trial of tocilizumab (TCZ) in patients with newly diagnosed polymyalgia rheumatica (PMR), conducted in Europe and the United States, has shown its efficacy and safety.ObjectivesWe examined the efficacy...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB0622 THE EFFICACY OF ADDITIONAL TOCILIZUMAB IN PATIENTS WITH SEVERE POLYMYALGIA RHEUMATICA WHO WERE RESISTANT TO OR INTOLERANT OF CONVENTIONAL THERAPY
Masahiro Yamamura ... Manami Hirata
-
Masahiro Yamamura, et. al.Masahiro Yamamura ... Manami Hirata
01 Jun 2019
FRI0266 THE REAL-WORLD EFFICACY OF THE 2015 EULAR/ACR RECOMMENDATIONS FOR THE MANAGEMENT OF POLYMYALGIA RHEUMATICA WITH ADDITIONAL TOCILIZUMAB THERAPY
M Yamamura
-
M YamamuraM Yamamura
01 Jun 2020
24-hour ocular perfusion pressure in glaucoma patients
K Mansouri ... R N Weinreb
British Journal of Ophthalmology | VOL. 95
K Mansouri, et. al.K Mansouri ... R N Weinreb
26 May 2011
THU0575 Tocilizumab Is Significantly Steroid-Sparing Compared with Methotrexate in Polymyalgia Rheumatica: A Multicenter Retrospective Study (NTMC-KEIO PMR Study)
M Ushikubo ... T Takeuchi
Annals of the Rheumatic Diseases | VOL. 75
M Ushikubo, et. al.M Ushikubo ... T Takeuchi
01 Jun 2016
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers